Lincoln Pharmaceuticals Ltd(IN:LINCOLN)
₹519.95-4.45 (-0.85%)
IN:LINCOLN
Lincoln Pharmaceuticals Ltd financials statements
₹519.95
At close:-4.45 (-0.85%)
Want to see IN:LINCOLN full AI Analyst Report?
Lincoln Pharmaceuticals Ltd (LINCOLN) Ratios
1 Followers
Lincoln Pharmaceuticals Ltd Ratios
IN:LINCOLN's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:LINCOLN's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.25 | 4.71 | 4.84 | 5.09 | 3.90 |
| Quick Ratio | 4.53 | 3.97 | 4.01 | 4.12 | 3.10 |
| Cash Ratio | 0.19 | 0.13 | 0.06 | 0.07 | 0.08 |
| Solvency Ratio | 0.77 | 0.76 | 0.97 | 0.97 | 0.76 |
| Operating Cash Flow Ratio | 0.96 | 0.88 | 0.69 | 0.54 | 0.84 |
| Short-Term Operating Cash Flow Coverage | 24.18 | 0.00 | 59.26 | 19.66 | 37.25 |
| Net Current Asset Value | ₹ 4.50B | ₹ 3.75B | ₹ 3.39B | ₹ 2.82B | ₹ 2.51B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.18 | 1.19 | 1.18 | 1.17 | 1.23 |
| Debt Service Coverage Ratio | 19.03 | 51.59 | 41.63 | 20.88 | 22.57 |
| Interest Coverage Ratio | 82.12 | 47.05 | 56.81 | 38.42 | 113.69 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.71 | 0.94 | 1.26 | 2.01 | 1.74 |
| Net Debt to EBITDA | -0.13 | -0.11 | -0.03 | -0.03 | -0.05 |
| Profitability Margins | |||||
| Gross Profit Margin | 32.81% | 53.26% | 51.24% | 51.33% | 52.60% |
| EBIT Margin | 17.38% | 17.82% | 21.22% | 20.22% | 20.80% |
| EBITDA Margin | 19.54% | 19.89% | 23.14% | 22.12% | 22.53% |
| Operating Profit Margin | 12.40% | 14.22% | 14.33% | 15.45% | 35.24% |
| Pretax Profit Margin | 17.23% | 17.52% | 21.06% | 19.90% | 20.49% |
| Net Profit Margin | 13.10% | 13.21% | 16.07% | 14.44% | 14.81% |
| Continuous Operations Profit Margin | 13.10% | 13.21% | 16.07% | 14.44% | 14.81% |
| Net Income Per EBT | 76.02% | 75.42% | 76.33% | 72.55% | 72.29% |
| EBT Per EBIT | 139.00% | 123.25% | 146.89% | 128.83% | 58.15% |
| Return on Assets (ROA) | 9.87% | 10.33% | 13.32% | 12.41% | 12.98% |
| Return on Equity (ROE) | 11.60% | 12.26% | 15.74% | 14.51% | 16.02% |
| Return on Capital Employed (ROCE) | 10.67% | 12.83% | 13.69% | 15.14% | 37.17% |
| Return on Invested Capital (ROIC) | 8.07% | 9.67% | 10.43% | 10.94% | 26.75% |
| Return on Tangible Assets | 9.88% | 10.34% | 13.33% | 12.42% | 12.99% |
| Earnings Yield | 7.77% | 7.44% | 7.79% | 10.73% | 11.15% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.77 | 3.09 | 2.83 | 3.11 | 3.09 |
| Payables Turnover | 5.31 | 3.43 | 3.91 | 4.80 | 4.36 |
| Inventory Turnover | 5.63 | 3.70 | 3.67 | 3.51 | 3.05 |
| Fixed Asset Turnover | 3.44 | 3.35 | 3.18 | 3.19 | 3.11 |
| Asset Turnover | 0.75 | 0.78 | 0.83 | 0.86 | 0.88 |
| Working Capital Turnover Ratio | 1.55 | 1.67 | 1.79 | 1.81 | 1.89 |
| Cash Conversion Cycle | 127.97 | 110.27 | 135.27 | 145.48 | 153.95 |
| Days of Sales Outstanding | 131.82 | 118.12 | 129.18 | 117.45 | 117.97 |
| Days of Inventory Outstanding | 64.85 | 98.58 | 99.50 | 104.01 | 119.64 |
| Days of Payables Outstanding | 68.70 | 106.43 | 93.40 | 75.98 | 83.66 |
| Operating Cycle | 196.68 | 216.70 | 228.68 | 221.46 | 237.61 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 53.39 | 46.44 | 31.56 | 19.60 | 38.01 |
| Free Cash Flow Per Share | 40.69 | 36.83 | 11.85 | 12.47 | 15.28 |
| Dividend Paid and CapEx Coverage Ratio | 3.68 | 4.07 | 1.49 | 2.27 | 1.57 |
| Capital Expenditure Coverage Ratio | 4.21 | 4.83 | 1.60 | 2.75 | 1.67 |
| Operating Cash Flow Coverage Ratio | 24.18 | 0.00 | 59.26 | 19.66 | 37.25 |
| Operating Cash Flow to Sales Ratio | 0.16 | 0.15 | 0.11 | 0.08 | 0.16 |
| Free Cash Flow Yield | 7.20% | 6.67% | 1.98% | 3.68% | 4.92% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.87 | 13.43 | 12.84 | 9.32 | 8.97 |
| Price-to-Sales (P/S) Ratio | 1.69 | 1.77 | 2.06 | 1.35 | 1.33 |
| Price-to-Book (P/B) Ratio | 1.49 | 1.65 | 2.02 | 1.35 | 1.44 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.88 | 14.99 | 50.45 | 27.20 | 20.33 |
| Price-to-Operating Cash Flow Ratio | 10.58 | 11.89 | 18.95 | 17.31 | 8.17 |
| Price-to-Earnings Growth (PEG) Ratio | 1.91 | -1.14 | 0.46 | 1.82 | 0.79 |
| Enterprise Value Multiple | 8.50 | 8.81 | 8.88 | 6.06 | 5.85 |
| Enterprise Value | 11.14B | 10.93B | 11.93B | 6.76B | 6.17B |
| EV to EBITDA | 8.50 | 8.81 | 8.88 | 6.06 | 5.85 |
| EV to Sales | 1.66 | 1.75 | 2.06 | 1.34 | 1.32 |
| EV to Free Cash Flow | 13.67 | 14.81 | 50.25 | 27.08 | 20.17 |
| EV to Operating Cash Flow | 10.42 | 11.75 | 18.87 | 17.23 | 8.11 |
| Tangible Book Value Per Share | 377.79 | 335.10 | 295.79 | 250.72 | 215.93 |
| Shareholders’ Equity Per Share | 378.25 | 335.31 | 295.96 | 250.86 | 216.12 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.25 | 0.24 | 0.27 | 0.28 |
| Revenue Per Share | 335.01 | 311.13 | 289.82 | 252.10 | 233.75 |
| Net Income Per Share | 43.88 | 41.11 | 46.58 | 36.40 | 34.63 |
| Tax Burden | 0.76 | 0.75 | 0.76 | 0.73 | 0.72 |
| Interest Burden | 0.99 | 0.98 | 0.99 | 0.98 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.20 | 0.18 | 0.18 | 0.04 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.22 | 0.85 | 0.68 | 0.39 | 0.79 |
Currency in INR

